Biospecifics Technologies (BSTC) Reports Q3 EPS of $0.39
Tweet
Share
E-mailGet Alerts BSTC Hot Sheet
Join SI Premium – FREE
Biospecifics Technologies (NASDAQ: BSTC) reported Q3 EPS of $0.39, versus $0.20 reported last year. Revenue for the quarter came in at $6.3 million versus the consensus estimate of $7.51 million.
For earnings history and earnings-related data on Biospecifics Technologies (BSTC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Jefferies Starts Bajaj Housing Finance (BAJAJHFL:IN) at Hold
- Beam Global (BEEM) Tops Q2 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
